Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
13.43
-0.09 (-0.67%)
At close: Dec 11, 2025, 4:00 PM EST
13.77
+0.34 (2.52%)
After-hours: Dec 11, 2025, 7:10 PM EST
Perrigo Company Revenue
Perrigo Company had revenue of $1.04B in the quarter ending September 27, 2025, a decrease of -4.06%. This brings the company's revenue in the last twelve months to $4.28B, down -2.51% year-over-year. In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%.
Revenue (ttm)
$4.28B
Revenue Growth
-2.51%
P/S Ratio
0.43
Revenue / Employee
$511,016
Employees
8,379
Market Cap
1.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
| Dec 31, 2018 | 4.73B | -214.50M | -4.34% |
| Dec 31, 2017 | 4.95B | -334.40M | -6.33% |
| Dec 31, 2016 | 5.28B | 1.05B | 24.92% |
| Jun 27, 2015 | 4.23B | 313.00M | 8.00% |
| Jun 28, 2014 | 3.91B | 374.30M | 10.57% |
| Jun 29, 2013 | 3.54B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PRGO News
- 8 days ago - Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
- 23 days ago - PERRIGO COMPANY PLC (NYSE: PRGO) INVESTOR ALERT Investors With Large Losses in Perrigo Company plc Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 23 days ago - Perrigo to Attend Morgan Stanley Global Consumer & Retail Conference - PRNewsWire
- 5 weeks ago - Perrigo Company plc (PRGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Perrigo begins strategic review of baby formula business - Reuters
- 5 weeks ago - Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations - PRNewsWire
- 5 weeks ago - Perrigo to Conduct Strategic Review of its Infant Formula Business - PRNewsWire
- 5 weeks ago - Perrigo to Attend Jefferies Consumer Conference - PRNewsWire